Silicosis Diagnosed Using Transbronchial Lung Biopsy: The Pivotal Role of Occupational History. [PDF]
Ng BH +6 more
europepmc +1 more source
This review systematically summarizes the major molecular mechanisms governing TAM polarization and their coordinated interactions. It further highlights recent advances in nanoagonist‐based strategies that intervene in these pathways to reprogram TAMs, critically discussing their therapeutic potential, current limitations, and translational prospects.
Siqi Fang +7 more
wiley +1 more source
Factors Influencing Diagnostic Yield and Complication Risk in CT-Guided Transthoracic Lung Biopsy of Pulmonary Lesions: A Retrospective Analysis. [PDF]
Mozerytė A +4 more
europepmc +1 more source
ABSTRACT Background Wound healing involves excessive oxidative stress and cellular dysfunction, while current single therapies remain inadequate. Astragalus polysaccharides (APS) and exosomes (Exos) possess antioxidative and regenerative properties, and gelatin methacryloyl (GelMA) hydrogel provides a biocompatible platform for localized delivery. Here,
Jingwen Tian +7 more
wiley +1 more source
Clinical and Procedural Predictive Model for Pneumothorax Risk After CT-Guided Lung Biopsy. [PDF]
Qin Y, Zhao Z, Zhang L, Shao X, Wang Q.
europepmc +1 more source
Transcriptomic Profiling of SLC and ABC Transporters in the Human Term Placenta
Solute carriers (SLC) and ATP‐binding cassette (ABC) transporters are essential for placental solute exchange and fetal protection, yet their transcriptomic profiles in the human placenta remain poorly characterized. Although fetal sex influences placental development and function, its impact on transporter expression is unclear.
Elijah Marsh Jung +12 more
wiley +1 more source
Massive hemothorax following CT-guided lung biopsy: A rare iatrogenic complication managed conservatively. [PDF]
Rasuli B, Yazdi AF.
europepmc +1 more source
Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit +6 more
wiley +1 more source
The Value of Lung Biopsy in Infants up to 3 Months With Diffuse Lung Disease in a Resource-Limited Setting. [PDF]
Goussard P +8 more
europepmc +1 more source

